The American Society of Clinical Oncology (ASCO) has reviewed complications associated with immune checkpoint inhibitor therapy. One complication is hemolytic anemia.
Patient: hemolytic anemia (presumably immune) associated with immune checkpoint inhibitor therapy
Parameters:
(1) hemoglobin in g/dL
(2) intervention required
Hemoglobin
Intervention
Grade
10 g/dL to LLN
none
G1
8.0 to 9.99
G2
< 8.0 g/dL
transfusion indicated
G3
urgent; life-threatening
G4
Grading assumes that the hemolytic anemia is the main determinant of the hemoglobin and required intervention.
To read more or access our algorithms and calculators, please log in or register.